Role of peripheral nerve stimulation in treating chronic neuropathic pain: an international focused survey of pain medicine experts

被引:9
|
作者
Li, Alice Huai-Yu [1 ]
Bhatia, Anuj [2 ]
Gulati, Amit [3 ]
Ottestad, Einar [4 ]
机构
[1] Stanford Univ, Dept Anesthesia, Stanford, CA USA
[2] Univ Toronto, Dept Anesthesia & Pain Med, Toronto, ON, Canada
[3] Mem Sloan Kettering Canc Ctr, Dept Anesthesiol & Crit Care, New York, NY USA
[4] Stanford Univ, Anesthesiol & Pain Med, Sch Med, Palo Alto, CA USA
关键词
pain management; peripheral nerve injuries; spinal cord stimulation; LOW-BACK-PAIN; MANAGEMENT; ALGORITHM; BURDEN; GUIDELINES;
D O I
10.1136/rapm-2022-104073
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Interventional pain management (IPM) options for refractory neuropathic pain (NP) have recently increased with availability of peripheral nerve stimulation (PNS) equipment and expertise. Given a lack of high-quality evidence and guidelines on this topic, we sought to understand the perception of physicians with expertise in treating NP regarding IPM and the role of PNS. We emailed a survey in March 2022 to international NP experts including pain medicine physicians, researchers, and leaders of 11 professional pain societies. No representatives from vendors of PNS systems were included in the design of the survey nor as respondents. Among 24 respondents (67% of those contacted), the distal common peroneal, tibial, and sural nerves were most frequently targeted (60%) with PNS. Persistent postsurgical pain of more than 3 months was the most common indication for PNS (84%). The aggregate NP treatment algorithm in order of median rank was non-opioid medications as first line, IPM including epidural/perineural steroid injections tied with transcutaneous electrical nerve stimulation as second line, pulsed radiofrequency (RF) tied with RF ablation/denervation as third line, temporary then permanent PNS as fourth line, followed by spinal cord stimulation, opioids, cryoablation, botulinum, peripheral nerve field stimulation, intrathecal targeted drug delivery, and others. Before offering PNS, 12 respondents (50%) indicated their preference for trialing non-neuromodulation treatments for 1-3 months. Twenty-two respondents (92%) agreed PNS should be offered early in the treatment of neuropathic pain. The most common barriers to PNS use were cost, lack of high-quality evidence in support of its use, lack of exposure to PNS in training programs, and lack of familiarity with the use of ultrasound guidance. PNS appears to have an increasing role in the treatment of NP but more research is needed on the outcomes of PNS to elucidate its role.
引用
收藏
页码:312 / 318
页数:7
相关论文
共 50 条
  • [41] Peripheral nerve stimulation for the treatment of chronic knee pain
    Frueh, Anton
    Sargut, Tarik Alp
    Hussein, Abdelhalim
    Muskala, Bartolomaeus
    Kuckuck, Anja
    Bruesseler, Melanie
    Vajkoczy, Peter
    Bayerl, Simon
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [42] Magnetic Peripheral Nerve Stimulation (mPNS) for Chronic Pain
    Bedder, Marshall
    Parker, Lisa
    JOURNAL OF PAIN RESEARCH, 2023, 16 : 2365 - 2373
  • [43] Peripheral nerve stimulation for the treatment of chronic knee pain
    Anton Früh
    Tarik Alp Sargut
    Abdelhalim Hussein
    Bartolomäus Muskala
    Anja Kuckuck
    Melanie Brüßeler
    Peter Vajkoczy
    Simon Bayerl
    Scientific Reports, 13
  • [44] PERIPHERAL-NERVE STIMULATION FOR RELIEF OF CHRONIC PAIN
    VANDERLINDEN, R
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1981, 8 (02) : 192 - 192
  • [45] The future of therapeutic peripheral nerve stimulation for chronic pain
    Beauchene, Christine
    Zurn, Claire A.
    Duan, Wanru
    Guan, Yun
    Sarma, Sridevi, V
    ANNUAL REVIEWS IN CONTROL, 2022, 54 : 377 - 385
  • [46] Temporary Peripheral Nerve Stimulation as Treatment for Chronic Pain
    Alaa Abd-Elsayed
    Mitchell K. Keith
    Nancy N. Cao
    Kenneth J. Fiala
    Joshua M. Martens
    Pain and Therapy, 2023, 12 : 1415 - 1426
  • [47] Temporary Peripheral Nerve Stimulation as Treatment for Chronic Pain
    Abd-Elsayed, Alaa
    Keith, Mitchell K.
    Cao, Nancy N.
    Fiala, Kenneth J.
    Martens, Joshua M.
    PAIN AND THERAPY, 2023, 12 (06) : 1415 - 1426
  • [48] Peripheral Nerve Stimulation for Chronic Pain and Migraine: A Review
    Erosa, Samantha C.
    Moheimani, Roya S.
    Oswald, Jessica C.
    Castellanos, Joel P.
    Abraham, Mickey E.
    Schuster, Nathaniel M.
    PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA, 2022, 33 (02) : 379 - 407
  • [49] Implantable Peripheral Nerve Stimulation for Peripheral Neuropathic Pain: A Systematic Review of Prospective Studies
    Char, Steven
    Jin, Max Y.
    Francio, Vinicius Tieppo
    Hussain, Nasir
    Wang, Eric J.
    Morsi, Mahmoud
    Orhurhu, Vwaire
    Prokop, Larry J.
    Fink, Adam
    D'Souza, Ryan S.
    BIOMEDICINES, 2022, 10 (10)
  • [50] Ultrasound-guided percutaneous peripheral nerve stimulation for chronic refractory neuropathic pain: a unique series
    Ferreira-Silva, Nuno
    Ferreira-Dos-Santos, Guilherme
    Gupta, Sahil
    Hunt, Christine L.
    Eldrige, Jason S.
    Pingree, Matthew J.
    Clendenen, Steven R.
    Hurdle, Mark Friedrich B.
    PAIN MANAGEMENT, 2023, 13 (01) : 15 - 24